Event Abstract

Development of a biomaterials-based functional epithelial graft for tracheal regeneration

  • 1 University of Toronto, Institute of Biomaterials and Biomedical Engineering, Canada
  • 2 Toronto General Hospital, Latner Thoracic Surgery Research Laboratories, Canada

Tracheal injury, stenosis, and malignancy demand surgical management or tracheal reconstruction [1],[2], however, the latter is an unmet clinical need as tracheal grafts and transplants fail due to the lack of a functioning epithelium and immune rejection. Tracheal immune rejection is largely associated with the epithelium, therefore we believe that the best method to optimize the use of donor tracheae is to decellularize only the epithelium and maintain the remaining tracheal structure, to replace it with a recipient-derived epithelium. We aim to develop a donor-recipient hybrid tracheal model by de-epithelializing the donor trachea and engrafting a pre-developed biomaterial-based recipient epithelial graft.

The absence of a functioning, ciliated, pseudostratified epithelium is a primary concern in tracheal regeneration. Clinically applied biomaterials demonstrate limited success in allowing proper airway epithelium growth and function [3]-[5]. Promising biomaterials have not been studied systematically. Therefore, we propose to perform the first comparative study to determine the optimal biomaterial for this context.          

Hyaluronan-Poly-ethylene glycol (HA-PEG), Chitosan-Collagen, Collagen Vitrigel Membrane, Gelatin, Silk Fibroin, and Fibrin-PEG diacrylate, were screened to identify substrates that promote airway epithelium (cell lines: BEAS-2B, A549, CALU-3, and primary human tracheal epithelial cells: HTECs) attachment, viability and function while possessing mechanical strength. Cell viability and proliferation on the biomaterials are assessed through Live/Dead staining and Ki-67 immunocytochemistry, respectively, while cell attachment is assessed via focal adhesion kinase and vinculin immunocytochemistry. Tight junction (zonula occludins-1) formation and differentiation of HTECs into ciliated (acetylated α-tubulin) and secretory cells (mucin 5AC) in air-liquid-interface culture is examined via immunocytochemistry.

Preliminary results of phase contrast microscopy revealed no attachment of BEAS-2Bs and HTECs on HA-PEG hydrogels (HA-PEG, HA-PEG with functionalized IKVAV peptide, and HA-PEG with functionalized RGD peptide) by day 7. There was limited attachment of A549s and BEAS-2Bs and no attachment of CALU-3s on Chitosan-Collagen by day 14, and successful attachment with epithelial sheet formation with all cell types on Silk Fibroin by day 14 of culture. Irregular tight junction formation on HTECs on Silk Fibroin is detected as early as day 14 of air-liquid-interface culture and organizes by day 45.

While Silk Fibroin is a promising biomaterial with exceptional mechanical strength [6], it demonstrates delayed maturation of HTECs and no ciliated cell differentiation by day 45 as opposed to day 21 on the Collagen I control.  Silk Fibroin can be coated with other matrix proteins to promote enhanced epithelial cell attachment and differentiation. A 72-hour extracellular matrix screen of thirty individual or matrix protein combinations demonstrates BEAS-2B and HTEC attachment to Fibronectin (50 µg/ml) + Laminin (100 µg/ml) and RGD Peptide (50 µg/ml) + Laminin (50 µg/ml), and little attachment to Collagen I (200 µg/ml or 400 µg/ml) which is often used as a standard control.

With further investigation, an optimal biomaterial will be selected to develop an airway epithelium graft for human tracheal regeneration. This study will have significant clinical implications for viable tracheal transplants in future and can serve as a stepping stone for regenerating other organs comprising an epithelium.

Dr. Molly Shoichet; Alexander Baker

References:
[1] Grillo, H. C. (2002) Tracheal Replacement: A Critical Review. Ann Thorac Surg.73:1995-2004
[2] Fishman, J.M., Lowdell, M., and Birchall, M. A. (2014) Stem cell-based organ replacements – Airway and lung tissue engineering. Semin. Pediatr. Surg. 23:119-126
[3] Jungebluth P., Go T., Asnaghi A., Bellini S., Martorell J., Calore C., Urbani L., Ostertag H., Mantero S., Conconi M. T., and Macchiarini P. (2009) Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix. J. Thorac. Cardiovasc. Surg. 138:586-593
[4] Lin, C-H., Hsu, S-H., Su, J. M., and Chen, C-W. (2010) Surface modification of poly(ε-caprolactone) porous scaffolds using gelatin hydrogel as the tracheal replacement. J. Tissue Eng. Regen. Med. 5:156-162
[5] Paz, A. C., Soleas, J., Poon, J. C. H., Trieu, D., Waddell, T. K., and McGuigan, A. P. (2014) Challenges and opportunities for tissue-engineering polarized epithelium. Tissue Eng. Part B. 20:56-72
[6] Partlow B. P., Hanna C. W., Rnjak-Kovacina J., Moreau J. E., Applegate M. B., Burke K. A., Marelli B., Mitropoulos A. N., Omenetto F. G., and Kaplan D. L. (2014) Highly tunable elastomeric silk biomaterials. Adv. Funct. Mater. 24:4615-4624

Keywords: Cell Adhesion, Extracellular Matrix, Tissue Engineering, Clinical relevance

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Biomaterials in constructing tissue substitutes

Citation: Varma R, Karoubi G and Waddell TK (2016). Development of a biomaterials-based functional epithelial graft for tracheal regeneration. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02981

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 28 Mar 2016; Published Online: 30 Mar 2016.